ReviewPediatric clinics of North America2012
Pediatric scleroderma: systemic or localized forms.
Review in Pediatric clinics of North America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Development of minimum standards of care for juvenile localized scleroderma.European journal of pediatrics · 2018Pooled it
- A linear indurated forehead lesion with scalp alopecia.JAAD case reports · 2026Article
- Outcomes of Fat Grafting in the Active Versus Quiescent Phase of Localized Scleroderma.Plastic surgery (Oakville, Ont.) · 2024Article
- Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses.Frontiers in immunology · 2024Review
- Disturbances of the stomatognathic system and possibilities of its correction in patients with craniofacial morphea.Postepy dermatologii i alergologii · 2023Review
- Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.Pediatric rheumatology online journal · 2023Article
- Clinical and Histopathological Features of Scleroderma-like Disorders: An Update.Medicina (Kaunas, Lithuania) · 2021Review
- DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.Clinical immunology (Orlando, Fla.) · 2021Article
- Spectrum of childhood interstitial and diffuse lung diseases at a tertiary hospital in Egypt.ERJ open research · 2021Article
- Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma.Journal of ultrasonography · 2021Article
- Secukinumab treatment of Parry-Romberg syndrome.JAAD case reports · 2020Article
- Sarcopenia in juvenile localized scleroderma: new insights on deep involvement.European radiology · 2020Article
- Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties.European journal of rheumatology · 2020Article
- Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.Pediatric rheumatology online journal · 2019Observational
- Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.ACR open rheumatology · 2019Article
- Evaluation of six-minute walk test in juvenile systemic sclerosis.Rheumatology international · 2019Article
- Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age.International journal of molecular sciences · 2019Review
- Congenital morphea profunda in a 7-year-old male patient with coexistence of fibrous hamartoma of infancy: a rare case report.Postepy dermatologii i alergologii · 2018Article
- Psychometric properties of the Children's Dermatology Life Quality Index in pediatric localized scleroderma.Journal of scleroderma and related disorders · 2018Article
- A 13-year-old girl with a linear dark patch on her forehead: A case of scleroderma en coup de sabre in a child with skin of color presenting with a bruise-like appearance.JAAD case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Pediatric scleroderma includes 2 major groups of clinical entities, systemic sclerosis (SSc) and localized scleroderma (LS). Although both share a common pathophysiology, their clinical manifestations differ. LS is typically confined to the skin and underlying subcutis, with up to a quarter of patients showing extracutaneous disease manifestations such as arthritis and uveitis. Vascular, cutaneous, gastrointestinal, pulmonary, and musculoskeletal involvement are most commonly seen in children with SSc. Treatment of both forms targets the active inflammatory stage and halts disease progression; however, progress needs to be made toward the development of more effective antifibrotic therapy to help reverse disease damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.